The Drug Monograph Digest is a curated database compiled from primary, publicly available sources, including but not limited to FDA approval letters, regulatory reviews, prescribing information, and Orange Book listings.
We curate this scattered information into standardized drug profiles that give professionals in pharmaceutical research and development, legal, and regulatory fields deep insight at a glance. It saves hours of research and helps shape business and investment strategy.
Why This Information Matters
Drug approval information is a treasure trove of valuable insight, but it is not easy to compile and use. The details are spread across approval letters, scientific reviews, and multiple registries. Pulling together the full story of a single drug is a cumbersome process. AI-assisted searches can help, but they are not fully reliable on their own. That is why we compile each profile with a human in the loop.* The Digest does that work upfront, so the information is already organized when you need it.
The Digest serves R&D scientists, pharmaceutical executives, regulatory affairs professionals, IP and legal counsel, and investors as they plan development strategies, evaluate intellectual property positions, or weigh investments.
* Human in the loop: every profile is compiled with the help of AI tools and then reviewed by a person before publication. While we work to keep the information accurate, errors may still occur. The Digest is provided for informational purposes only and should not be the sole basis for regulatory, legal, or investment decisions.